160 related articles for article (PubMed ID: 6573117)
21. C5a receptor.
Huey R; Hugli TE
Methods Enzymol; 1987; 150():615-27. PubMed ID: 3431434
[No Abstract] [Full Text] [Related]
22. Complement activation and endotoxin in sepsis.
Padalino P; Gardinali M; Pallavicini J; Chiara O; Bisiani G; Nespoli A
Prog Clin Biol Res; 1989; 308():277-82. PubMed ID: 2780700
[No Abstract] [Full Text] [Related]
23. Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages.
Chenoweth DE; Goodman MG; Weigle WO
J Exp Med; 1982 Jul; 156(1):68-78. PubMed ID: 7086356
[TBL] [Abstract][Full Text] [Related]
24. In vivo clearance and tissue distribution of C5a and C5a des arginine complement fragments in rabbits.
Webster RO; Larsen GL; Henson PM
J Clin Invest; 1982 Dec; 70(6):1177-83. PubMed ID: 7174788
[TBL] [Abstract][Full Text] [Related]
25. C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients.
Lewis SL; Van Epps DE; Chenoweth DE
Clin Nephrol; 1986 Jul; 26(1):37-44. PubMed ID: 3488153
[TBL] [Abstract][Full Text] [Related]
26. Monokine generation as a consequence of binding of human C5a anaphylatoxin to specific cell-surface receptors.
Goodman MG
Lymphokine Res; 1984; 3(1):7-10. PubMed ID: 6332253
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
van Epps DE; Chenoweth DE
J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
[TBL] [Abstract][Full Text] [Related]
28. Airways hyperreactivity and inflammation produced by aerosolization of human C5A des arg.
Irvin CG; Berend N; Henson PM
Am Rev Respir Dis; 1986 Oct; 134(4):777-83. PubMed ID: 3767132
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of a new photoreactive C5a analog that permits identification of the ligand binding component of the granulocyte C5a receptor.
Johnson RJ; Chenoweth DE
Biochem Biophys Res Commun; 1987 Nov; 148(3):1330-7. PubMed ID: 3689398
[TBL] [Abstract][Full Text] [Related]
30. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
Oppermann M; Götze O
Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
[TBL] [Abstract][Full Text] [Related]
31. Complement fragments, alveolar macrophages, and alveolitis.
Henson PM; McCarthy K; Larsen GL; Webster RO; Giclas PC; Dreisin RB; King TE; Shaw JO
Am J Pathol; 1979 Oct; 97(1):93-110. PubMed ID: 495697
[TBL] [Abstract][Full Text] [Related]
32. Endotoxin-induced shock in the rat. A role for C5a.
Smedegård G; Cui LX; Hugli TE
Am J Pathol; 1989 Sep; 135(3):489-97. PubMed ID: 2789475
[TBL] [Abstract][Full Text] [Related]
33. Identification of classical anaphylatoxin as the des-Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des-Arg74-C5a.
Gerard C; Hugli TE
Proc Natl Acad Sci U S A; 1981 Mar; 78(3):1833-7. PubMed ID: 6940191
[TBL] [Abstract][Full Text] [Related]
34. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.
Kew RR; Webster RO
J Clin Invest; 1988 Jul; 82(1):364-9. PubMed ID: 3392213
[TBL] [Abstract][Full Text] [Related]
35. [Immunologic defense mechanism of complement-derived inflammatory chemical mediators].
Yamamoto T; Kambara T
Nihon Rinsho; 1988 Sep; 46(9):1974-80. PubMed ID: 3266512
[No Abstract] [Full Text] [Related]
36. Rapid and simple measurement of human C5a-des-Arg level in plasma or serum using monoclonal antibodies.
Takeda J; Kinoshita T; Takata Y; Kozono H; Tanaka E; Hong K; Inoue K
J Immunol Methods; 1987 Aug; 101(2):265-70. PubMed ID: 3611800
[TBL] [Abstract][Full Text] [Related]
37. Structure and function of human C5a anaphylatoxin. Selective modification of tyrosine 23 alters biological activity but not antigenicity.
Johnson RJ; Chenoweth DE
J Biol Chem; 1985 Aug; 260(18):10339-45. PubMed ID: 2410424
[TBL] [Abstract][Full Text] [Related]
38. Complement activation and vascular injury in systemic lupus erythematosus.
Abramson S; Belmont HM; Hopkins P; Buyon J; Winchester R; Weissmann G
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():43-6. PubMed ID: 2886660
[TBL] [Abstract][Full Text] [Related]
39. Solubilization of the functional C5a receptor from human polymorphonuclear leukocytes.
Rollins TE; Siciliano S; Springer MS
J Biol Chem; 1988 Jan; 263(1):520-6. PubMed ID: 3335507
[TBL] [Abstract][Full Text] [Related]
40. Attachment of human C5a des Arg to its cochemotaxin is required for maximum expression of chemotactic activity.
Perez HD; Chenoweth DE; Goldstein IM
J Clin Invest; 1986 Dec; 78(6):1589-95. PubMed ID: 3782473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
